4.4 Article

Pathophysiology of Erectile Dysfunction

Journal

CURRENT DRUG TARGETS
Volume 16, Issue 5, Pages 411-419

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/138945011605150504114041

Keywords

Angiotensin; erectile dysfunction; nitric oxide; pathophysiology; reactive oxygen species; RhoA/Rho-associated protein kinase; tumor necrosis factor-alpha

Ask authors/readers for more resources

Erectile dysfunction (ED) is a major health problem as the population ages. Basic science research for the last two decades has expanded the knowledge on ED and identified several key molecular changes associated with the pathogenesis of ED, including nitric oxide (NO)/cyclic guanosine monophosphate (cGMP)/protein kinase G (PKG) pathway, RhoA/Rho-associated protein kinase (ROCK) signaling pathway, reactive oxygen species (ROS), renin-angiotensin system (RAS) and tumor necrosis factor-alpha (TNF-alpha). The causes of ED are classified into aging, vasculogenic, neurogenic, endocrinological, drug-induced and psychogenic. ED is often associated with systemic diseases, such as diabetes and cardiovascular diseases. In this review, we will review the molecular mechanisms of ED and known mechanisms behind ED associated with systemic diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available